File Photo
For years, weight-loss injections and pills have dominated headlines, often promising dramatic results but leaving users concerned about side effects and long-term risks. Now, researchers in China believe they may have found a gentler, food-based solution that could help people shed pounds without needles or surgery.
A team from Sichuan University has created tiny edible microbeads made from green tea polyphenols, vitamin E, and seaweed. When consumed, these plant-based beads bind to fats in the gut, blocking their absorption in a natural and noninvasive way.
“Losing weight can help some people prevent long-term health issues like diabetes and heart disease,” explained Yue Wu, a graduate student at Sichuan University, in findings presented at the American Chemical Society and reported by The Sun UK. “Our microbeads work directly in the gut to block fat absorption in a gentle way.”
How they work inside the body
The innovation lies in the design. The beads are coated with a natural seaweed-derived polymer, which shields them from stomach acid. Once they reach the intestine, the coating expands, releasing green tea polyphenols and vitamin E to bind with partially digested fats. These trapped fats are then passed out of the body instead of being absorbed.
The beads are nearly tasteless, which means they could be easily added to everyday meals. Researchers believe this makes them an accessible and practical alternative to existing weight-loss treatments.
Promising results in animal studies
To test the approach, scientists fed three groups of rats different diets for 30 days: one high-fat diet with microbeads, one high-fat diet without them, and a normal diet. The results were striking. Rats on the high-fat diet supplemented with microbeads lost about 17 percent of their total body weight, while the other groups showed no significant change.
“These ingredients are food-grade and FDA-approved, and their production can be easily scaled up,” said Yunxiang He, associate professor at Sichuan University and co-author of the study.
Human trials now underway
Encouraged by the animal results, the team has already launched a human clinical trial in collaboration with West China Hospital. So far, 26 participants have been enrolled, and the first data is expected within a year.
“This represents a major step toward clinical translation of our polyphenol-based microbeads,” Wu said.
Source: Online/OFA
Comment Now